High Death Risk Tied to mTOR Drugs in Cancer MedPage Today "Use of mTOR inhibitors is associated with a small, but significant increased risk of developing a fatal adverse event," said Choueiri, of Dana-Farber Cancer Institute in Boston. "I do want to emphasize that both study drugs, everolimus and ... |
